BIOMAT Database Logo BIOMAT Database Logo

N-alkyloxycarbonyl derivatives of ethylene diamine as monoamine oxidase inhibitors. 1998

V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
Institute of Biomedical Chemistry, Academy of Medical Sciences, Moscow, Russia.

A series of urethane type derivatives of ethylene diamine (EDA) was synthesised and tested as inhibitors of monoamine oxidase (MAO) A and B. Nature of aromatic ring and a position of substituents in it were important for the inhibitory activity. Chlorobenzyloxycarbonyl-EDA derivatives exhibited selective inhibition of MAO-A with 3,4-Cl2-C6H4CH2OCO-EDA being a most potent and selective MAO-A inhibitor (IC50 4 microM). Within the compounds studied, 3,4-dichloro-benzyloxycarbonyl-EDA exhibited most potent inhibition of MAO-A. This compound inhibited the activity of rat liver MAO-A non-competitively with Ki (slope) value of 3.6 microM, whereas the inhibition of rat liver MAO-B was competitive with Ki (slope) value of 56 microM (not shown). 2.4-Dichlorobenzyloxycarbonyl-EDA also inhibited rat liver MAO-A in a non-competitive manner with Ki of 14.6 microM.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005029 Ethylenediamines Derivatives of ethylenediamine (the structural formula NH2CH2CH2NH2).
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
Monoamine oxidase inhibition by N-alkyloxycarbonyl derivatives of ethylene diamine.
September 2000, Biochemistry. Biokhimiia,
V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors.
March 2009, Bioorganic & medicinal chemistry,
V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
Amphetamine Derivatives as Monoamine Oxidase Inhibitors.
January 2019, Frontiers in pharmacology,
V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase.
October 1960, Biochemical pharmacology,
V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
Aziridine derivatives as potential monoamine oxidase inhibitors.
March 1966, Journal of medicinal chemistry,
V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
3-Coumaranone derivatives as inhibitors of monoamine oxidase.
January 2015, Drug design, development and therapy,
V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
α-Tetralone derivatives as inhibitors of monoamine oxidase.
June 2014, Bioorganic & medicinal chemistry letters,
V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
Selected chromone derivatives as inhibitors of monoamine oxidase.
September 2012, Bioorganic & medicinal chemistry letters,
V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
MONOAMINE OXIDASE INHIBITORS. HYDRAZINE DERIVATIVES.
May 1964, Journal of medicinal chemistry,
V F Pozdnev, and A Z Kirkel, and N S Kamyshanskaya, and L N Axenova, and A E Medvedev
Monoamine oxidase inhibitors and other drugs as inhibitors of diamine oxidase from human placenta and pig kidney.
November 1974, Biochemical pharmacology,
Copied contents to your clipboard!